Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.75 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.70 |
| ▸ | HRH1 | P35367 | 2/20 | 0.69 |
| ▸ | HRH3 | Q9Y5N1 | 7/20 | 0.65 |
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.63 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.59 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.59 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.59 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.59 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7923386 | 0.90 | LTA4H (0.64) | LTA4HSIGMAR1HRH1HRH3L3MBTL3 | |
| SCHEMBL20382580 | 0.90 | LTA4H (0.86) | LTA4HSIGMAR1HRH3SLC6A3GRIN2B | |
| SCHEMBL7997735 | 0.90 | SIGMAR1 (0.65) | LTA4HSIGMAR1HRH1HRH3L3MBTL3 | |
| SCHEMBL7982901 | 0.90 | HRH3 (0.73) | LTA4HSIGMAR1HRH1HRH3L3MBTL3 | |
| SCHEMBL14549517 | 0.90 | LTA4H (0.64) | LTA4HSIGMAR1HRH1HRH3L3MBTL3 | |
| SCHEMBL11955057 | 0.90 | SIGMAR1 (0.65) | LTA4HSIGMAR1HRH1HRH3L3MBTL3 | |
| SCHEMBL2326201 | 0.90 | LTA4H (0.64) | LTA4HSIGMAR1HRH1HRH3L3MBTL3 | |
| SCHEMBL14501468 | 0.90 | HRH1 (0.86) | LTA4HSIGMAR1HRH1HRH3L3MBTL3 | |
| SCHEMBL22813547 | 0.90 | SCN5A (0.71) | LTA4HSIGMAR1HRH1HRH3SLC6A3 | |
| SCHEMBL5302082 | 0.89 | LTA4H (0.86) | LTA4HSIGMAR1HRH3SLC6A3GRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108290749-B | Novel synthetic crystalline EMM-28 material, its preparation and use | 埃克森美孚科技工程公司 | 2022-06-24 | — | — | CN | disclosed |
| US-20220023827-A1 | EMM-41 Composition, Methods of Making and Uses Thereof | EXXONMOBIL RES & ENG CO (US) | 2022-01-27 | — | — | US | disclosed |
| EP-3383796-B1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2020-09-16 | — | — | EP | disclosed |
| EP-3383796-B1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2020-09-16 | — | — | EP | disclosed |
| US-10597300-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2019-07-18 | — | — | US | disclosed |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2019-07-18 | — | — | US | disclosed |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| EP-3383796-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | Exxonmobil Research And Engineering Company (US) | 2018-10-10 | — | — | EP | disclosed |
| WO-2017095705-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-06-08 | — | — | WO | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| WO-2017095705-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220023827-A1 | EMM-41 Composition, Methods of Making and Uses Thereof | CD14, CD68, MASP2 | LTA4H 1757/4885SIGMAR1 4161/4885HRH1 4159/4885 |
| US-10597300-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | LTA4H 3486/4885SIGMAR1 3782/4885HRH1 2899/4885 |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | LTA4H 3486/4885SIGMAR1 3782/4885HRH1 2899/4885 |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | LTA4H 3486/4885SIGMAR1 3782/4885HRH1 2899/4885 |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | LTA4H 3486/4885SIGMAR1 3782/4885HRH1 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.